EUVIMEDEUVIMED entdecken
Open Access

Optimizing Piperacillin Dosing in Pediatric Liver Transplant Recipients: A Case Series

Ronaldo Morales Junior iD, Anhar Hosawi iD, Sonya Tang Girdwood iD, Min Dong iD, Vanessa D' Amaro Juodinis iD, Paschoalina Romano iD, Pérsio de Almeida Rezende Ebner iD, Nilo José Coelho Duarte iD, Daniela Carla de Souza iD, Silvia Regina Cavani Jorge Santos iD

Pediatric Transplantation · 2024

DOI: 10.1111/petr.14860 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pediatric Transplantation, 2024. Verfasst von Ronaldo Morales Junior und 9 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Pharmacokinetics Center, School of Pharmaceutical Sciences, University of São Paulo, São Paulo, São Paulo, Brazil. Hauptthemen laut MEDLINE: Liver Transplantation, Anti-Bacterial Agents, Piperacillin, Piperacillin, Tazobactam Drug Combination. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, National Institute of General Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Pathophysiological changes post‐liver transplantation impact the pharmacokinetics and pharmacodynamics of antibiotics. Piperacillin, often used in combination with tazobactam, is a key antibiotic after transplantation to its broad‐spectrum activity, but there is a lack of specific pharmacokinetic data in this population. This study aims to describe the pharmacokinetic parameters and target attainment of piperacillin in pediatric liver transplant recipients.

Methods

Patients with preserved renal function (estimated glomerular filtration rate > 50 mL/min/1.73 m 2 ) receiving intravenous piperacillin‐tazobactam at 112.5 mg/kg every 8 h (100 mg piperacillin/12.5 mg tazobactam), with a rapid infusion (0.5–1 h), were included. Two blood samples per child were collected during the same interval within 48 h of starting therapy. A Bayesian approach was applied to estimate individual pharmacokinetic parameters and perform dosing recommendations against Enterococcus spp., Enterobacterales and Pseudomonas aeruginosa .

Results

Eight patients with median age of 8 months were included. Median piperacillin clearance and central volume of distribution for the cohort were 11.11 L/h/70 kg and 9.80 L/70 kg, respectively. Seven patients (87.5%) presented with concentrations below the target of 100% f T > MIC. Simulations suggested that these patients required more frequent dosing and extended duration of infusion to ensure target attainment. One patient (12.5%) had trough concentrations that exceed 16 mg/L and could receive a lower daily dose.

Conclusions

This case series highlights the importance of personalized therapy in pediatric liver transplant recipients due to the unpredictable and highly variable piperacillin pharmacokinetics in this population.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver TransplantationAnti-Bacterial AgentsPiperacillinPiperacillin, Tazobactam Drug CombinationHumansMaleFemaleInfantChild, PreschoolBayes TheoremChild

Stichwörter der Autor:innen

Bayesian approachbeta‐lactamliver transplantationprecision dosing

Substanzen

Anti-Bacterial AgentsPiperacillinPiperacillin, Tazobactam Drug Combination

Autor:innen und Institutionen

  • Clinical Pharmacokinetics Center, School of Pharmaceutical Sciences, University of São Paulo, São Paulo, São Paulo, Brazil.
  • Pediatric Unit, Hospital Sírio-libanês, São Paulo, São Paulo, Brazil.
  • Division of Translational and Clinical Pharmacology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
  • Department of Pharmacology and Systems Physiology, University of Cincinnati, Cincinnati, Ohio, USA.
  • Division of Hospital Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
  • Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.

ORCID-Profile: Ronaldo Morales Junior, Anhar Hosawi, Sonya Tang Girdwood, Min Dong, Vanessa D' Amaro Juodinis, Paschoalina Romano, Pérsio de Almeida Rezende Ebner, Nilo José Coelho Duarte, Daniela Carla de Souza, Silvia Regina Cavani Jorge Santos

Förderung

  • NIGMS NIH HHS
  • National Institute of General Medical Sciences

Zitieren

APA

Morales Junior, R., Hosawi, A., Tang Girdwood, S., Dong, M., Juodinis, V. A., Romano, P., Ebner, P. A. R., Duarte, N. J. C., de Souza, D. C., & Santos, S. R. C. J. (2024). Optimizing Piperacillin Dosing in Pediatric Liver Transplant Recipients: A Case Series. Pediatric Transplantation. https://doi.org/10.1111/petr.14860

Vancouver

Morales Junior R, Hosawi A, Tang Girdwood S, Dong M, Juodinis VA, Romano P, et al. Optimizing Piperacillin Dosing in Pediatric Liver Transplant Recipients: A Case Series. Pediatric Transplantation. 2024. doi:10.1111/petr.14860

BibTeX
@article{MoralesJunior2024,
  author = {Morales Junior, Ronaldo and Hosawi, Anhar and Tang Girdwood, Sonya and Dong, Min and Juodinis, Vanessa D' Amaro and Romano, Paschoalina and Ebner, Pérsio de Almeida Rezende and Duarte, Nilo José Coelho and de Souza, Daniela Carla and Santos, Silvia Regina Cavani Jorge},
  title = {Optimizing Piperacillin Dosing in Pediatric Liver Transplant Recipients: A Case Series},
  journal = {Pediatric Transplantation},
  year = {2024},
  doi = {10.1111/petr.14860}
}
Kostenlos starten →